Biochemical Predictors of Response to Neoadjuvant Therapy in Pancreatic Ductal Adenocarcinoma.

Awad, Seifeldin; Alkashash, Ahmad M; Amin, Magi; Baker, Samantha J; Rose, J Bart

Awad, Seifeldin; Alkashash, Ahmad M; Amin, Magi; Baker, Samantha J; Rose, J Bart.

Afiliação

Awad S; Department of Surgical Oncology, University of Alabama in Birmingham, Birmingham, AL, United States.
Alkashash AM; Department of Surgical Oncology, University of Alabama in Birmingham, Birmingham, AL, United States.
Amin M; Department of Gastroenterology, Cairo Fatimid Hospital, Cairo, Egypt.
Baker SJ; Department of Surgical Oncology, University of Alabama in Birmingham, Birmingham, AL, United States.
Rose JB; Department of Surgical Oncology, University of Alabama in Birmingham, Birmingham, AL, United States.

Front Oncol ; 10: 620, 2020.

Article em En | MEDLINE | ID: mdl-32477933

Palavras-chave

CA 19-9carbohydrate antigen 19-9; biomarker (development); neoadjuvant chemotheraphy; pancreatic duct adenocarcinoma (PDAC); tumor biomarker

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google